Delivery Order SPE2DR25D2206-SPE2DR26F9FJ4
- Not listed
- The Defense Logistics Agency awarded a $14,061.54 delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL syringes on October 29, 2025, with a completion date of November 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $12,348.90 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml syringes on November 13, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order, which was not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a $2,469.78 delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. This non-set-aside, firm fixed-price contract is scheduled for completion by December 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $4,939.58 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL syringes on November 3, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of November 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under...
- The Defense Logistics Agency awarded a $9,879.12 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors, with an ultimate completion date of December 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $24,697.80 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. This firm fixed-price contract, with an ultimate completion date of December 29, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,469.78 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for completion by December 24, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,469.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen on December 1, 2025, with completion targeted for December 22, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Tezspire 210 mg/1.91 mL syringes with a ceiling value of $49,395.60. The award was made on December 10, 2025, with an ultimate completion date of January 2, 2026, utilizing firm fixed pricing under a non-set-aside competitive procurement. This delivery order represents a child contract under AmerisourceBergen's...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 14, 2025, calls for the supply of Tezspire 210 mg/1.91 mL syringes with a ceiling value of $9,374.36. The order represents a firm fixed-price delivery under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The Defense Logistics Agency is funding this...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9FJ4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes valued at $9,879.12, with an ultimate completion date of January 5, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion valuation through December 2026. The pharmaceutical product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. The IDC vehicle through which this delivery order is issued encompasses a comprehensive global pharmaceutical support program enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order reflects the contractor's established capability to fulfill federal pharmaceutical procurement requirements through open competition and demonstrates the company's role in supplying specialized healthcare commodities to the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 12/10/25 |